213 related articles for article (PubMed ID: 21831295)
1. Repression of human activation induced cytidine deaminase by miR-93 and miR-155.
Borchert GM; Holton NW; Larson ED
BMC Cancer; 2011 Aug; 11():347. PubMed ID: 21831295
[TBL] [Abstract][Full Text] [Related]
2. miR-29b directly targets activation-induced cytidine deaminase in human B cells and can limit its inappropriate expression in naïve B cells.
Recaldin T; Hobson PS; Mann EH; Ramadani F; Cousins DJ; Lavender P; Fear DJ
Mol Immunol; 2018 Sep; 101():419-428. PubMed ID: 30081328
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs miR-155 and miR-16 Decrease AID and E47 in B Cells from Elderly Individuals.
Frasca D; Diaz A; Romero M; Ferracci F; Blomberg BB
J Immunol; 2015 Sep; 195(5):2134-40. PubMed ID: 26223652
[TBL] [Abstract][Full Text] [Related]
4. Ago2 and a miRNA reduce Topoisomerase 1 for enhancing DNA cleavage in antibody diversification by activation-induced cytidine deaminase.
Kobayashi M; Wakaguri H; Shimizu M; Higasa K; Matsuda F; Honjo T
Proc Natl Acad Sci U S A; 2023 May; 120(18):e2216918120. PubMed ID: 37094168
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic p95HER2 regulates Na+-HCO3- cotransporter NBCn1 mRNA stability in breast cancer cells via 3'UTR-dependent processes.
Gorbatenko A; Olesen CW; Loebl N; Sigurdsson HH; Bianchi C; Pedraz-Cuesta E; Christiansen J; Pedersen SF
Biochem J; 2016 Nov; 473(21):4027-4044. PubMed ID: 27609814
[TBL] [Abstract][Full Text] [Related]
6. miR-106b fine tunes ATG16L1 expression and autophagic activity in intestinal epithelial HCT116 cells.
Zhai Z; Wu F; Chuang AY; Kwon JH
Inflamm Bowel Dis; 2013 Oct; 19(11):2295-301. PubMed ID: 23899543
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation.
Dorsett Y; McBride KM; Jankovic M; Gazumyan A; Thai TH; Robbiani DF; Di Virgilio M; Reina San-Martin B; Heidkamp G; Schwickert TA; Eisenreich T; Rajewsky K; Nussenzweig MC
Immunity; 2008 May; 28(5):630-8. PubMed ID: 18455451
[TBL] [Abstract][Full Text] [Related]
8. Effects of ARHI on breast cancer cell biological behavior regulated by microRNA-221.
Li Y; Liu M; Zhang Y; Han C; You J; Yang J; Cao C; Jiao S
Tumour Biol; 2013 Dec; 34(6):3545-54. PubMed ID: 23801152
[TBL] [Abstract][Full Text] [Related]
9. ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.
Duhachek-Muggy S; Zolkiewska A
BMC Cancer; 2015 Mar; 15():93. PubMed ID: 25886595
[TBL] [Abstract][Full Text] [Related]
10. The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.
Zheng L; Li X; Gu Y; Lv X; Xi T
Breast Cancer Res Treat; 2015 Feb; 150(1):105-18. PubMed ID: 25701119
[TBL] [Abstract][Full Text] [Related]
11. Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer.
Li X; Xu Y; Ding Y; Li C; Zhao H; Wang J; Meng S
Mol Cancer; 2018 Aug; 17(1):113. PubMed ID: 30068375
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-16 modulates HuR regulation of cyclin E1 in breast cancer cells.
Guo X; Connick MC; Vanderhoof J; Ishak MA; Hartley RS
Int J Mol Sci; 2015 Mar; 16(4):7112-32. PubMed ID: 25830480
[TBL] [Abstract][Full Text] [Related]
14. Activation-induced cytidine deaminase (AID) is necessary for the epithelial-mesenchymal transition in mammary epithelial cells.
Muñoz DP; Lee EL; Takayama S; Coppé JP; Heo SJ; Boffelli D; Di Noia JM; Martin DI
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):E2977-86. PubMed ID: 23882083
[TBL] [Abstract][Full Text] [Related]
15. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE.
Kaga H; Komatsuda A; Omokawa A; Ito M; Teshima K; Tagawa H; Sawada K; Wakui H
Mod Rheumatol; 2015; 25(6):865-70. PubMed ID: 25775145
[TBL] [Abstract][Full Text] [Related]
16. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1.
Cui J; Cheng Y; Zhang P; Sun M; Gao F; Liu C; Cai J
J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660
[TBL] [Abstract][Full Text] [Related]
17. TIP60-miR-22 axis as a prognostic marker of breast cancer progression.
Pandey AK; Zhang Y; Zhang S; Li Y; Tucker-Kellogg G; Yang H; Jha S
Oncotarget; 2015 Dec; 6(38):41290-306. PubMed ID: 26512777
[TBL] [Abstract][Full Text] [Related]
18. Lipid raft-mediated miR-3908 inhibition of migration of breast cancer cell line MCF-7 by regulating the interactions between AdipoR1 and Flotillin-1.
Li Y; Shan F; Chen J
World J Surg Oncol; 2017 Mar; 15(1):69. PubMed ID: 28327197
[TBL] [Abstract][Full Text] [Related]
19. Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.
Romero M; Gapihan G; Castro-Vega LJ; Acevedo A; Wang L; Li ZW; El Bouchtaoui M; Di Benedetto M; Ratajczak P; Feugeas JP; Thieblemont C; Saavedra C; Janin A
Oncotarget; 2017 Mar; 8(10):16243-16258. PubMed ID: 27806315
[TBL] [Abstract][Full Text] [Related]
20. MiR-107 suppresses proliferation of hepatoma cells through targeting HMGA2 mRNA 3'UTR.
Wang Y; Chen F; Zhao M; Yang Z; Zhang S; Ye L; Gao H; Zhang X
Biochem Biophys Res Commun; 2016 Nov; 480(3):455-460. PubMed ID: 27773820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]